Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1215.4000 22.40 (1.88%)
NSE Jan 02, 2026 15:31 PM
Volume: 516.1K
 

logo
Aurobindo Pharma Ltd.
06 Jun 2016
1215.40
1.88%
Economic Times
The company paid its CEO, M Govindarajan, an average annual compensation of Rs 9.5 crore, which is above the average CEO salary during the period.
Aurobindo Pharma Ltd.'s price crossed above 30Day SMA today
Aurobindo Pharma gets best value from payout to CEO in 3 years
Economic Times | 06 Jun 2016
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - January 2, 2026
The Baseline | 02 Jan 2026, 05:55PM
Market closes higher, led by a rally in auto stocks
Trendlyne Marketwatch | 02 Jan 2026, 04:04PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020